146 related articles for article (PubMed ID: 35156528)
1. COVID-19 in patients with chronic lymphocytic leukemia: a Moscow observational study.
Kochneva ОL; Kislova M; Zhelnova EI; Petrenko AA; Baryakh EA; Yatskov KV; Dmitrieva EA; Misurina EN; Nikitin KE; Vasilieva EJ; Samsonova IV; Ptushkin VV; Baranova A; Nikitin EA
Leuk Lymphoma; 2022 Jul; 63(7):1607-1616. PubMed ID: 35156528
[TBL] [Abstract][Full Text] [Related]
2. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L; Chatzikonstantinou T; Rigolin GM; Quaresmini G; Motta M; Vitale C; Garcia-Marco JA; Hernández-Rivas JÁ; Mirás F; Baile M; Marquet J; Niemann CU; Reda G; Munir T; Gimeno E; Marchetti M; Quaglia FM; Varettoni M; Delgado J; Iyengar S; Janssens A; Marasca R; Ferrari A; Cuéllar-García C; Itchaki G; Špaček M; De Paoli L; Laurenti L; Levin MD; Lista E; Mauro FR; Šimkovič M; Van Der Spek E; Vandenberghe E; Trentin L; Wasik-Szczepanek E; Ruchlemer R; Bron D; De Paolis MR; Del Poeta G; Farina L; Foglietta M; Gentile M; Herishanu Y; Herold T; Jaksic O; Kater AP; Kersting S; Malerba L; Orsucci L; Popov VM; Sportoletti P; Yassin M; Pocali B; Barna G; Chiarenza A; Dos Santos G; Nikitin E; Andres M; Dimou M; Doubek M; Enrico A; Hakobyan Y; Kalashnikova O; Ortiz Pareja M; Papaioannou M; Rossi D; Shah N; Shrestha A; Stanca O; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Coscia M; Stamatopoulos K; Rossi G; Rambaldi A; Montserrat E; Foà R; Cuneo A; Ghia P
Leukemia; 2020 Sep; 34(9):2354-2363. PubMed ID: 32647324
[TBL] [Abstract][Full Text] [Related]
5. BCL-2 Inhibition as Treatment for Chronic Lymphocytic Leukemia.
Perini GF; Feres CCP; Teixeira LLC; Hamerschlak N
Curr Treat Options Oncol; 2021 Jun; 22(8):66. PubMed ID: 34110507
[TBL] [Abstract][Full Text] [Related]
6. Survival improvement of patients with chronic lymphocytic leukemia (CLL) in routine care 1995-2017.
Weide R; Feiten S; Chakupurakal G; Friesenhahn V; Kleboth K; Köppler H; Lutschkin J; van Roye C; Thomalla J; Heymanns J
Leuk Lymphoma; 2020 Mar; 61(3):557-566. PubMed ID: 31682164
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Šimkovič M; Turcsányi P; Špaček M; Mihályová J; Ryznerová P; Maco M; Vodárek P; Écsiová D; Poul H; Móciková H; Zuchnická J; Panovská A; Lekaa M; Oršulová M; Prchlíková A; Stejskal L; Mašlejová S; Brychtová Y; Bezděková L; Papajík T; Lysák D; Trněný M; Smolej L; Doubek M
Ann Hematol; 2023 Apr; 102(4):811-817. PubMed ID: 36847805
[TBL] [Abstract][Full Text] [Related]
8. The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
Visentin A; Chatzikonstantinou T; Scarfò L; Kapetanakis A; Demosthenous C; Karakatsoulis G; Minga E; Chamou D; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Besikli-Dimou S; Bron D; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Delgado J; Dimou M; Donaldson D; Catherwood M; Doubek M; Efstathopoulou M; Eichhorst B; Elashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Collado R; Gentile M; Gimeno E; Glenthøj A; da Silva MG; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Rigolin GM; Ruchlemer R; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Tadmor T; Capasso A; Del Poeta G; Gutwein O; Karlsson LK; Milosevic I; Mirás F; Reda G; Saghumyan G; Shrestha A; Te Raa D; Tonino SH; Van Der Spek E; van Gelder M; van Kampen R; Wasik-Szczepanek E; Wróbel T; Segundo LYS; Yassin M; Pocali B; Vandenberghe E; Iyengar S; Varettoni M; Vitale C; Coscia M; Rambaldi A; Montserrat E; Cuneo A; Stavroyianni N; Trentin L; Stamatopoulos K; Ghia P
Am J Hematol; 2023 Dec; 98(12):1856-1868. PubMed ID: 37772428
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study.
Molica S; Giannarelli D; Lentini M; Zappala D; Mannella A; Loiacono D; Gianfelici V; Panduri G; Gariani I; Minchella P; Talarico F; Levato L
Chemotherapy; 2022; 67(2):91-95. PubMed ID: 34872098
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Benjamini O; Rokach L; Itchaki G; Braester A; Shvidel L; Goldschmidt N; Shapira S; Dally N; Avigdor A; Rahav G; Lustig Y; Ben David SS; Fineman R; Paz A; Bairey O; Polliack A; Levy I; Tadmor T
Haematologica; 2022 Mar; 107(3):625-634. PubMed ID: 34320789
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.
Archibald WJ; Rabe KG; Kabat BF; Herrmann J; Ding W; Kay NE; Kenderian SS; Muchtar E; Leis JF; Wang Y; Chanan-Khan AA; Schwager SM; Koehler AB; Fonder AL; Slager SL; Shanafelt TD; Call TG; Parikh SA
Ann Hematol; 2021 Jan; 100(1):143-155. PubMed ID: 32488603
[TBL] [Abstract][Full Text] [Related]
12. Real-World Treatment Patterns, Adverse Events, Resource Use, and Costs Among Commercially Insured, Younger Patients with Chronic Lymphocytic Leukemia in the USA: A Retrospective Cohort Study.
Kabadi SM; Near A; Wada K; Burudpakdee C
Adv Ther; 2020 Jul; 37(7):3129-3148. PubMed ID: 32399812
[TBL] [Abstract][Full Text] [Related]
13. Venetoclax alone or in combination with other regimens treatment achieve deep and sustained remission of relapsed/refractory chronic lymphocytic leukemia: a meta-analysis.
Tang X; Zou W; Peng P; Bai Y
Clin Exp Med; 2022 May; 22(2):161-171. PubMed ID: 34224006
[TBL] [Abstract][Full Text] [Related]
14. Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Barrientos JC; O'Brien S; Brown JR; Kay NE; Reddy NM; Coutre S; Tam C; Mulligan S; Jaeger U; Devereux S; Pocock C; Robak T; Schuster SJ; Schuh A; Gill D; Bloor A; Dearden C; Moreno C; Cull G; Hamblin M; Jones JA; Eckert K; Solman IG; Suzuki S; Hsu E; James DF; Byrd JC; Hillmen P
Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):803-813.e7. PubMed ID: 30249389
[TBL] [Abstract][Full Text] [Related]
15. Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia.
Bagacean C; Letestu R; Al-Nawakil C; Brichler S; Lévy V; Sritharan N; Delmer A; Dartigeas C; Leblond V; Roos-Weil D; Tomowiak C; Merabet F; Béné MC; Clavert A; Chaoui D; Genet P; Guieze R; Laribi K; Drénou B; Willems L; Puppinck C; Legendre H; Troussard X; Malartre S; Cymbalista F; Michallet AS
Blood Adv; 2022 Jan; 6(1):207-211. PubMed ID: 34844264
[TBL] [Abstract][Full Text] [Related]
16. Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma.
Kreiniz N; Bejar J; Polliack A; Tadmor T
Hematol Oncol; 2018 Feb; 36(1):349-354. PubMed ID: 28156016
[TBL] [Abstract][Full Text] [Related]
17. Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia.
Hou JZ; Ryan K; Du S; Fang B; Marks S; Page R; Peng E; Szymanski K; Winters S; Le H
Future Oncol; 2021 Dec; 17(35):4959-4969. PubMed ID: 34783255
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Harel R; Itchaki G
Acta Haematol; 2024; 147(1):60-72. PubMed ID: 37820599
[TBL] [Abstract][Full Text] [Related]
19. Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population.
Goyal RK; Nagar SP; Kabadi SM; Le H; Davis KL; Kaye JA
Cancer Med; 2021 Apr; 10(8):2690-2702. PubMed ID: 33734606
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort.
Merli M; Ferrarini I; Merli F; Busca A; Mina R; Falini B; Bruna R; Cairoli R; Marchetti M; Romano A; Cavo M; Arcaini L; Trentin L; Cattaneo C; Derenzini E; Fracchiolla NS; Marchesi F; Scattolin A; Billio A; Bocchia M; Massaia M; Gambacorti-Passerini C; Mauro FR; Gentile M; Mohamed S; Della Porta MG; Coviello E; Cilloni D; Visani G; Federici AB; Tisi MC; Cudillo L; Galimberti S; Gherlinzoni F; Pagano L; Guidetti A; Bertù L; Corradini P; Passamonti F; Visco C
Hematol Oncol; 2023 Feb; 41(1):128-138. PubMed ID: 36265128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
